The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC).
 
Robin Kate Kelley
Consulting or Advisory Role - Agios (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst)
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Exelixis (Inst); Lilly (Inst); MedImmune (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)
 
Emily Mitchell
No Relationships to Disclose
 
Spencer Behr
Research Funding - GE Healthcare (Inst)
 
Jimmy Hwang
No Relationships to Disclose
 
Bridget Keenan
No Relationships to Disclose
 
Alexander Cheung
Employment - Genentech/Roche (I)
Stock and Other Ownership Interests - Bavarian Nordic; Genentech/Roche (I)
 
John Dozier Gordan
No Relationships to Disclose
 
Andrew H. Ko
Honoraria - Advance Medical; Med IQ; Medscape; Peerview
Consulting or Advisory Role - ARMO Biosciences; EMD Serono; Genentech/Roche; Halozyme; Incyte; Merrimack; New B Innovation; Seagen
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Acerta Pharma (Inst); Aduro Biotech (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Halozyme (Inst); Merck (Inst); Merrimack (Inst); PRISM BioLab (Inst)
 
Pelin Cinar
Consulting or Advisory Role - Celgene
Research Funding - Newlink Genetics
Travel, Accommodations, Expenses - Celgene
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Genentech; Kura Oncology
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Guardant Health; Merck; Novartis
Travel, Accommodations, Expenses - Roche
 
Katherine Van Loon
Consulting or Advisory Role - Bayer (Inst)
 
Thomas Weber
No Relationships to Disclose
 
Zoe Ngo
No Relationships to Disclose
 
Zoe E. Quandt
Stock and Other Ownership Interests - Bristol-Myers Squibb; Genomic Health; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - AbbVie (I)
 
Chienying Liu
No Relationships to Disclose
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences; Merrimack
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Serono (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Merck Serono; Merrimack; Roche; Taiho Pharmaceutical
 
Lawrence Fong
Consulting or Advisory Role - Atreca; IDEAYA Biosciences; MIODx
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Nektar (Inst); Roche/Genentech (Inst)